Mandaviya inaugurates 40 new facilities to manufacture bulk drugs, medical devices

Mandaviya said that during the COVID-19 pandemic, the dangers of the supply chain getting affected, the risks of being highly dependent on imports of critical resources like bulk drugs and medical devices and its potential effects on India's pharma and MedTech sector led to a lot of brainstorming within the central government.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wh8EJf5
via